Cargando…

Medical Costs and Resource Utilization for Hemophilia Patients With and Without HIV or HCV Infection

BACKGROUND: Previous research has shown that hemophilia patients infected in the 1980s with human immunodeficiency virus (HIV) and/or hepatitis C virus (HCV) from the blood supply have increased morbidity and mortality. Although the possibility of contracting HIV or HCV through contaminated blood pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tencer, Thomas, Friedman, Howard S., Li-McLeod, Josephine, Johnson, Kathleen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438209/ https://www.ncbi.nlm.nih.gov/pubmed/18062730 http://dx.doi.org/10.18553/jmcp.2007.13.9.790

Ejemplares similares

Understanding the impact of unequal utilization of medical services on the consumption of resources in hemophilia
por: Li, Lele, et al.
Publicado: (2022)

Costs and utilization of treatment in patients with hemophilia
por: Rocha, Patrícia, et al.
Publicado: (2015)

Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia
por: Thorat, Teja, et al.
Publicado: (2018)

Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection
por: Xiao, Hong, et al.
Publicado: (2019)

Resource utilization and treatment costs of patients with severe hemophilia A: Real‐world data from the ATHNdataset
por: Recht, Michael, et al.
Publicado: (2022)

HCV Genotypes of People with Hemophilia in Countries with High Seroprevalances
por: Mahlangu, J N, et al.
Publicado: (2011)

Health care utilization and expenditures of parents of children with and without hemophilia A
por: Kim, Eunice, et al.
Publicado: (2022)

Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study
por: Johnson, Terence L, et al.
Publicado: (2014)

Health care resource utilization and costs among adult patients with hemophilia A on factor VIII prophylaxis: an administrative claims analysis
por: Croteau, Stacy E, et al.
Publicado: (2021)

Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
por: Colombo, Giorgio L, et al.
Publicado: (2011)

Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar
por: Marquez, Lara K, et al.
Publicado: (2021)

Medical costs and hospital utilization for hemophilia A and B urban inpatients in China: a national cross-sectional study
por: Huang, Zhengwei, et al.
Publicado: (2022)

Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy
por: Andreoni, Massimo, et al.
Publicado: (2021)

Health care costs and resource use of managing hemophilia A: A targeted literature review
por: Chen, Yilin, et al.
Publicado: (2023)

Evaluation of clinical characteristics, health care resource utilization, and cost outcomes of hemophilia A carriers and noncarriers in the United States: A real-world comparative analysis
por: Xing, Shan, et al.
Publicado: (2023)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Comparing Hospital-Based Resource Utilization and Costs for Prostate Cancer Patients With and Without Bone Metastases
por: Seal, Brian, et al.
Publicado: (2014)

Health Care Costs and Resource Utilization Among Patients With Crohn’s Disease With and Without Perianal Fistula
por: Chen, Grace, et al.
Publicado: (2021)

Costs of the management of hemophilia A with inhibitors in Spain
por: Bonanad, Santiago, et al.
Publicado: (2021)

Comparative Assessment of Medical Resource Use and Costs Associated with Patients with Symptomatic Peripheral Artery Disease in the United States
por: Chase, Monica Reed, et al.
Publicado: (2016)

The Impact of “Emergency-only” Hemodialysis on Hospital Cost and Resource Utilization
por: Shafqat, Farina, et al.
Publicado: (2023)

First Report of Prevalence of Blood-Borne Viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) Among Hemophilia Patients in Afghanistan
por: Mousavi, Sayed Hamid, et al.
Publicado: (2019)

Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment
por: Ehret, Robert, et al.
Publicado: (2014)

Healthcare utilization, quality of life, and work productivity associated with primary hyperoxaluria: a cross-sectional web-based US survey
por: Goldfarb, David S., et al.
Publicado: (2023)

Mortality, healthcare resource utilization, and cost among Medicare beneficiaries with Clostridioides difficile infection with and without sepsis
por: Amin, Alpesh, et al.
Publicado: (2022)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

Portal vein thrombosis in a patient with HCV cirrhosis and combined hemophilia A and thrombophilia V Leiden
por: Eleftheriadis, Nikos, et al.
Publicado: (2010)

Utilization Patterns of Coagulation Factor Consumption for Patients with Hemophilia
por: Lee, Soo Ok, et al.
Publicado: (2016)

Practices and challenges for hemophilia management under resource constraints in Thailand
por: Moonla, Chatphatai, et al.
Publicado: (2023)

Direct Medical Care Costs Associated With Patients Diagnosed With Chronic HCV
por: Ashtari, Sara, et al.
Publicado: (2013)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection
por: Feuth, Thijs, et al.
Publicado: (2013)

Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease
por: Katrak, Shereen, et al.
Publicado: (2016)

Dual chamber pacing mode in an atrial antitachycardia pacing device without a ventricular lead – A necessary evil
por: Noheria, Amit, et al.
Publicado: (2015)

Modelling the impact and cost‐effectiveness of non‐governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine
por: Stone, Jack, et al.
Publicado: (2023)

A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity
por: Teng, Andrea M., et al.
Publicado: (2017)

Health care resource utilization and costs among individuals with vs without Huntington disease in a US population
por: To, Tu My, et al.
Publicado: (2022)

Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients
por: Imai, Koubun, et al.
Publicado: (2020)

Assessment of healthcare measures, healthcare resource use, and cost of care among severe hemophilia A patients in Mumbai region of India
por: Jadhav, U, et al.
Publicado: (2018)

Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy
por: La Mura, Vincenzo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kvt084i6hefu4kmo8olnom2idm